Trials / Completed
CompletedNCT02060019
Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects
A Phase I Clinical Trial to Investigate the Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- HK inno.N Corporation · Industry
- Sex
- Male
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study is designated to evaluate the pharmacokinetic interactions of amlodipine besylate, valsartan and rosuvastatin in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | administration of exforge 10/160mg for 3days. Next 7days administration of exforge 10/160mg and crestor 20mg. |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-06-01
- Completion
- 2014-12-01
- First posted
- 2014-02-11
- Last updated
- 2016-12-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02060019. Inclusion in this directory is not an endorsement.